Heterogeneity of treatment effect in SPRINT by age and baseline comorbidities: The greatest impact of intensive blood pressure treatment is observed among younger patients without CKD or CVD and in older patients with CKD or CVD
In: The Journal of Clinical Hypertension, Jg. 22 (2020-08-16), S. 1723-1726
Online
unknown
Zugriff:
The Systolic Blood Pressure Intervention Trial (SPRINT), a large randomized controlled trial funded by the National Institutes of Health, randomized 9361 patients with hypertension over 50 years of age and at least one cardiovascular risk factor to intensive (SBP
Titel: |
Heterogeneity of treatment effect in SPRINT by age and baseline comorbidities: The greatest impact of intensive blood pressure treatment is observed among younger patients without CKD or CVD and in older patients with CKD or CVD
|
---|---|
Autor/in / Beteiligte Person: | Tang, Maxine C. ; Rostomian, Ara ; Soverow, Jonathan ; Sanchez, Daniel R. |
Link: | |
Zeitschrift: | The Journal of Clinical Hypertension, Jg. 22 (2020-08-16), S. 1723-1726 |
Veröffentlichung: | Wiley, 2020 |
Medientyp: | unknown |
ISSN: | 1751-7176 (print) ; 1524-6175 (print) |
DOI: | 10.1111/jch.13955 |
Schlagwort: |
|
Sonstiges: |
|